Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics

Dennis Y Q Wang1, Luca Cardelli, Andrew Phillips

  • 1MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. dyqw2@cam.ac.uk

BMC Systems Biology
|December 24, 2009
PubMed
Abstract

Insights

Functional redundancy in the upstream epidermal growth factor receptor (EGFR) pathway maintains robustness. Downstream components like Ras and ERK have fewer redundancies, making them sensitive to inhibition. Abstract models aid understanding of complex signaling networks.

Area of Science:

  • Systems Biology
  • Computational Biology
  • Cell Signaling

Background:

  • The epidermal growth factor receptor (EGFR) pathway is crucial for cellular growth and development, but its complex orchestration remains incompletely understood.
  • Extensive interconnections within the EGFR pathway contribute to its complexity, necessitating advanced analytical approaches.
  • Understanding EGFR signaling is vital for deciphering cellular regulation and potential therapeutic interventions.

Purpose of the Study:

  • To identify critical mechanisms controlling signal transduction within the EGFR pathway.
  • To analyze an executable model of the EGFR pathway using stochastic pi-calculus.
  • To investigate the role of functional redundancy and feedback loops in EGFR signaling.

Main Methods:

  • Extensive analysis and simulation of an executable model of the EGFR pathway.
  • Utilizing stochastic pi-calculus as the modeling language for pathway analysis.
  • Developing and simulating an abstract model to capture key control mechanisms.

Main Results:

  • EGFR pathway exhibits functional redundancy in upstream regions, ensuring robustness against low EGF stimulus or system failures.
  • Downstream components, including Ras and ERK regulators, show limited redundancy; over 50% inhibition significantly reduces signal response.
  • Identified positive feedback loops prolong key component activity (e.g., MEK-PP, Ras-GTP) and negative feedback loops stabilize and adapt the signal.

Conclusions:

  • Simulations provide testable hypotheses for EGFR signaling control mechanisms.
  • Abstract executable models are beneficial for understanding large, complex biological networks.
  • Insights into pathway redundancy and feedback loops enhance comprehension of EGFR signal transduction.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...